IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 45, Pages 6315-6324
Publisher
Springer Nature
Online
2017-07-17
DOI
10.1038/onc.2017.236
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation
- (2017) Kouhei Tsuchida et al. FREE RADICAL BIOLOGY AND MEDICINE
- Small Molecule Inhibitor of NRF2 Selectively Intervenes Therapeutic Resistance in KEAP1-Deficient NSCLC Tumors
- (2016) Anju Singh et al. ACS Chemical Biology
- NRF2 Intensifies Host Defense Systems to Prevent Lung Carcinogenesis, but After Tumor Initiation Accelerates Malignant Cell Growth
- (2016) H. Satoh et al. CANCER RESEARCH
- Critical Contribution of Nuclear Factor Erythroid 2-related Factor 2 (NRF2) to Electrophile-induced Interleukin-11 Production
- (2016) Takashi Nishina et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming
- (2016) Tetsuya Saito et al. Nature Communications
- Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
- (2015) Santiago Zelenay et al. CELL
- Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer
- (2015) Cameron N. Johnstone et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis
- (2015) Maki Goto et al. GENES TO CELLS
- NRF2 regulates serine biosynthesis in non–small cell lung cancer
- (2015) Gina M DeNicola et al. NATURE GENETICS
- Molecular Pathways: IL11 as a Tumor-Promoting Cytokine--Translational Implications for Cancers
- (2014) M. Ernst et al. CLINICAL CANCER RESEARCH
- NF-E2-related factor 2 promotes compensatory liver hypertrophy after portal vein branch ligation in mice
- (2014) Keiichi Shirasaki et al. HEPATOLOGY
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Activation of the NRF2 pathway and its impact on the prognosis of anaplastic glioma patients
- (2014) Masayuki Kanamori et al. NEURO-ONCOLOGY
- IL-11: A Prominent Pro-Tumorigenic Member of the IL-6 Family
- (2013) Sergei I. Grivennikov CANCER CELL
- Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
- (2013) Tracy L. Putoczki et al. CANCER CELL
- NRF2 immunolocalization in human breast cancer patients as a prognostic factor
- (2013) Yoshiaki Onodera et al. ENDOCRINE-RELATED CANCER
- Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis
- (2013) Anju Singh et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- The Cancer Genome Atlas Pan-Cancer analysis project
- (2013) John N Weinstein et al. NATURE GENETICS
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Toward clinical application of the Keap1–Nrf2 pathway
- (2013) Takafumi Suzuki et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- MicroRNA-30c targets cytoskeleton genes involved in breast cancer cell invasion
- (2012) Jessica Bockhorn et al. BREAST CANCER RESEARCH AND TREATMENT
- Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
- (2012) Yoichiro Mitsuishi et al. CANCER CELL
- Roles of Keap1-Nrf2 System in Upper Aerodigestive Tract Carcinogenesis
- (2012) A. Ohkoshi et al. Cancer Prevention Research
- Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma
- (2012) Daisuke Inoue et al. CANCER SCIENCE
- Transcriptional regulation of the interleukin-11 gene by oncogenic Ras
- (2012) S. Y. Shin et al. CARCINOGENESIS
- Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity
- (2012) S Chowdhry et al. ONCOGENE
- Interleukin-11 Links Oxidative Stress and Compensatory Proliferation
- (2012) T. Nishina et al. Science Signaling
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism
- (2012) Yoichiro Mitsuishi et al. Frontiers in Oncology
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- SCF/ -TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent Manner
- (2011) P. Rada et al. MOLECULAR AND CELLULAR BIOLOGY
- The Keap1–Nrf2 system as an in vivo sensor for electrophiles
- (2011) Akira Uruno et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance
- (2010) Anju Singh et al. ANTIOXIDANTS & REDOX SIGNALING
- Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
- (2010) Hironori Satoh et al. CARCINOGENESIS
- Genetic Analysis of Cytoprotective Functions Supported by Graded Expression of Keap1
- (2010) K. Taguchi et al. MOLECULAR AND CELLULAR BIOLOGY
- Nrf2 Enhances Cell Proliferation and Resistance to Anticancer Drugs in Human Lung Cancer
- (2009) S. Homma et al. CLINICAL CANCER RESEARCH
- Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
- (2008) X.-J. Wang et al. CARCINOGENESIS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy
- (2008) T. Shibata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now